Our Biomedical Research Centre (BRC) is the result of an outstanding partnership between University College London Hospitals NHS Foundation Trust (UCLH) and UCL (University College London). Our full name is the NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London.
UCLH is one of the largest NHS trusts in the United Kingdom and UCL is one of the leading biomedical research universities. By working together we have become leaders in translating fundamental biomedical research into clinical research that benefits patients.
The National Institute for Health Research (NIHR) awarded us BRC status in 2007. With BRC status, we have been able to build on our expertise in areas such as cancer, cardiovascular disease and neurosciences.
What we do
The BRC supports research by investing in staff posts, equipment, facilities and training.
We take innovations in basic science and help turn them into treatments and therapies that have a direct effect on patients and often save lives.
We support in particular experimental medicine research which tends to be ‘first in man’ studies such as research into new therapies and devices or the mechanisms of disease. We will be investing over £111m in experimental medicine over the next 5 years.
What is experimental medicine?
By experimental medicine we mean early phase human translational studies focusing on:
- new therapies (drug, immunological and cell based) and novel devices and first-in-man studies
- improvements in diagnosis, treatment selection and evaluation of response – including diagnostics and medical technology
- repurposing of therapies.
This kind of research needs specialist infrastructure and skilled staff, often based in dedicated clinical research facilities.
Our strategic plan
Click here to read a report on our progress in implementing our strategic plan.
A review of our progress
Read our Research with Impact 2016/17 booklet for an annual update of our work.
Click here to read 'Focusing on experimental medicine: A review of our progress 2013/14'
Highlights of our 2007–2011 funding
Click here to read 'Building research infrastructures: Highlights of our 2007–2011 funding'